LEESBURG, Va.–(BUSINESS WIRE)–K2M, Inc., a spinal
device company developing innovative solutions for the treatment of complex
spinal pathologies and minimally invasive procedures, today debuted two
additions to the family of ALEUTIAN® Interbody Systems at the 2011 North
American Spine Society (NASS) Annual Meeting in Chicago.
Furthering the companys commitment to continue to enhance
its extensive product portfolio, the ALEUTIAN Transforaminal-Lumbar (TLIF) II
Interbody System features a full range of unique bulleted PEEK interbodies for
posterior lumbar applications. The ALEUTIAN TILF II will include the Adjustable
Inserter, which allows for variable angulation of the implant from 0° to 55°
in-situ, helping the surgeon to insert the TLIF interbody with precision and
ease. For oblique implant placement through a transforaminal-lumbar approach,
the ALEUTIAN Anatomically-Narrow (AN) Oblique Interbody System offers
innovative instrumentation that helps facilitate more efficient intraoperative
use of the system.
“The bulleted nose of the ALEUTIAN TLIF II implant
simplifies interbody insertion and the open-structure design provides a
substantial amount of room for graft material. The implant features, combined
with state-of-the-art instrument technology, makes the ALEUTIAN TLIF II
Interbody System a great choice for my patients who require a transforaminal
interbody fusion,” stated Dr. George Miz, Orthopedic Surgeon at Bone and Joint
Physicians.
The clinical application of the ALEUTIAN
Transforaminal-Lumbar II Interbody System will be shown in a Hands-On
Demonstration at NASS, today from 10:00 – 10:30 am Central (K2M Booth #1616).
“K2Ms debut of two new next generation products in the
ALEUTIAN family of products demonstrates our dedication to developing and
improving upon our rapidly growing portfolio,” stated Eric Major, K2Ms
President and CEO. “Given the significant expansion of our global distribution
team and the number of new and existing customers in need of high quality
interbody systems, it is critical that we continue to introduce new
technologies.”
About K2M
K2M, Inc. is an innovative spinal device company committed to the research,
development, and commercialization of simplified solutions for the treatment of
complex spinal pathologies and minimally invasive procedures. The company is
recognized as a worldwide leader in providing unique technologies for the
treatment of deformity, degenerative, trauma, and tumor spinal patients. K2Ms
complete portfolio of next generation products includes: spinal stabilization
systems, minimally invasive systems, and other advancing technologies such as
motion preservation, annular repair, and nucleus replacement. Additional
information is available online at www.K2M.com.
